Stock screener

VRTX

Conviction 75HealthcareScan · Mon, Jul 20, 2026
Bearish engulfing
VRTX$480.67-1.03%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
2
Vol MA14 1.66M
Apr 20May 6May 26Jun 11Jul 1Jul 20
VERTEX PHARMACEUTICALS INC / MAPHARMACEUTICAL PREPARATIONSwww.vrtx.com
Price480.67
Change-1.03%
Gap+0.31%
Rel volume1.04×
Avg volume2.01M
Avg $ vol990.95M
SMA 20491.13
SMA 50460.97
SMA 200449.76
Price vs 50+4.27%
Price vs 200+6.87%
MA stackbullish
50/200 cross
Supertrenddown · 519.77
RSI (14)51
MACD hist-4.09
MACD crossbear · 6d
Stoch %K / %D17 / 23
ADX (14)27
+DI / −DI25 / 19
RSI divergence
MACD divergence
ATR %+2.92%
ADR %2.97%
52w high529.59
52w low366.54
From 52w high-9.24%
Above 52w low+31.14%
New 52w highNo
SqueezeOff
Bollinger width14.41%
%B0.35
Donchian pos34.13%
Donchian high533.67
Donchian low453.21
AVWAP (52w high)493.13
vs AVWAP high-2.53%
AVWAP (52w low)441.73
vs AVWAP low+8.81%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d1.04×
Avg vol (14d)1.66M
Avg vol (20d)2.01M
Avg $ vol (20d)990.95M
Market cap122B
RS 3m (vs SPY)+5.54%
RS 6m (vs SPY)+0.37%
RS line new highNo
Trend template8/8
Technical rank72.4
1 week+0.09%
1 month+4.72%
3 months+8.95%
6 months+9.51%
1 year+3.76%
YTD+6.31%
P/E30.86
P/B6.30
P/S10.17
P/FCF38.20
EPS15.32
Div yield
ROE20.42%
ROA14.93%
Debt/Eq0.01
Current3.02
EV/EBITDA26.60
Gross margin
Net margin32.94%
Rev growth8.90%
EPS growth838.09%
Price target558.30
Target upside16.15%
Analyst ratingBuy
Institutional104.60%
Ent. value116.61B
Revenue2.99B
Net income1.03B
Gross profit
Free cash flow3.19B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out253.81M
Employees6.4K
ListedWed, Jul 31, 1991
Free float253.88M
Float %99.8%
Short interest4.94M
Days to cover2.0d
Short volume47.9%
Squeeze score20 / 100
Next earningsMon, Aug 3, 2026 · after (14d)
EPS forecast$4.25 · 6 est
Last EPS vs est$3.95 vs $3.69
Last surprise+7.0% beat
Setup gradeA
Conviction75 / 100
Pattern quality
Tech rank72.4 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRTX · 9 recent

All disclosures →
MemberSideAmount
David J. Taylor
David J. Taylor
house · R · OH · traded 2025-08-07
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2024-12-11
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-10
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Byron Donalds
Byron Donalds
house · R · FL · traded 2025-03-20
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-13
Buy$15K–$50K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-02-24
Buy$15K–$50K
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in VRTX · 2 buys · 8 sells

InsiderSideShares
SACHS BRUCE I
Director · Deferred Stock Units · 2026-07-15
Grant99.941
Garber Alan M
Director · Deferred Stock Units · 2026-07-15
Grant31.56
McKechnie Duncan
EVP, Chief Commercial Officer · Common Stock · 2026-07-02
Sell1.54K
Tatsis Ourania
EVP, Chief Reg. & Quality Off. · Common Stock · 2026-07-02
Sell1.5K
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-26
Sell596
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-15
Sell4.06K
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-05
Sell1.75K
Liu Joy
EVP and Chief Legal Officer · Common Stock · 2026-06-01
Sell828
Bozic Carmen
EVP and CMO · Common Stock · 2026-05-29
Sell1.97K
Bunnage Mark E.
EVP, Chief Scientific Officer · Common Stock · 2026-05-15
Sell33

SEC filings

EDGAR filings in VRTX · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.